Form 8-K IRONWOOD PHARMACEUTICALS For: Aug 14
Last ironwood pharmaceuticals, inc earnings: 2/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations: investor.ironwoodpharma.com
| Impact snapshot | Event time: | IRWD | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last price | ||
| VWAP | ||
|
High:
|
Max up |
High:
|
|
Low:
|
Max down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event Day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance Since Event
Time and Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY
Opt-in for
IRWD alerts
IRWD alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRWD alerts
High impacting Ironwood Pharmaceuticals, Inc news events
Weekly update
A roundup of the hottest topics
IRWD
News
- Ironwood Pharmaceuticals Appoints Jay P. Shepard to Board of DirectorsBusiness Wire
- Ironwood Pharmaceuticals, Inc. (<a href="https://www.marketbeat.com/stocks/NASDAQ/IRWD/price-target/">NASDAQ: IRWD</a>) was upgraded by analysts at TheStreet from a "d+" rating to a "c-" rating.MarketBeat
- Ironwood Pharmaceuticals, Inc.'s (IRWD) CEO Mark Mallon on Q3 2020 Results - Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Ironwood Pharmaceuticals to Present at the 29th Annual Credit Suisse Healthcare ConferenceBusiness Wire
- Ironwood Pharmaceuticals, Inc. (<a href="https://www.marketbeat.com/stocks/NASDAQ/IRWD/price-target/">NASDAQ: IRWD</a>) had its price target raised by analysts at Credit Suisse Group AG from $11.00 to $12.00. They now have a "neutral" ratMarketBeat
- More
IRWD
SEC Filings
- 12/3/20 - Form 4
- 12/3/20 - Form 3
- 12/3/20 - Form 8-K
- IRWD's page on the SEC website
- More